Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Managing multiple autoimmune diseases in one patient is extremely challenging.

Superficial cryotherapy significantly improves eyebrow hair growth in alopecia universalis patients.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Satoyoshi syndrome can cause hair loss and other serious health issues, and is hard to diagnose.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Topical PUVA and tacrolimus ointment can effectively and safely treat infant alopecia universalis.

Azelaic acid's effectiveness in treating certain skin conditions needs more research.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Vitamin D might help treat some types of hair loss, but more research is needed.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Combining ciclosporin and simvastatin can cause severe kidney damage.

An Australian with rare hair loss and eye conditions had a gene linked to both, not seen together before.